Exelixis, Inc. Financials

Market Capitalization $12.08 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	20.23
Forward PE	26.06
Price to Sales TTM	$5.26
Price to Book MRQ	$5.72
Enterprise to Revenue	4.86
Enterprise to EBITDA	13.24

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	27.99%
Operating Margin	33.64%
Return on Assets TTM	18.05%
Return on Equity TTM	30.22%

Income Statement

Revenue TTM	$2,298,921,984
Revenue per Share TTM	$8.08
Quarterly Revenue Growth	30.60%
Gross Profit TTM	$2,224,790,016
EBITDA	$896,778,000
Net Income to Common TTM	$643,566,016
Diluted EPS TTM	$2.19
Quarterly Earnings Growth YoY	327.70%

Balance Sheet

Total Cash MRQ	$1,031,315,968
Total Cash per Share MRQ	$3.78
Total Debt MRQ	$
Total Debt to Equity MRQ	8.78
Current Ratio MRQ	3.50
Book Value per Share MRQ	$7.75

Cash Flow

Operating Cash Flow TTM	$842,585,984
Levered Free Cash Flow TTM	$559,125,376

EXEL Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	281,732,000
Float Shares	232,276,550
Avg 10 Volume	4,573,424
Avg 30 Volume	None
Shares Short	20,385,497
Short Ratio	5.53
Short % of Shares	10.26%
% Held by Insiders	2.20%
% Held by Institutions	93.99%

Stock Price Summary

Beta	0.29
Fifty Two Week Low	$21.86
Fifty Two Week High	$49.62
Fifty Two Week Change	52.11%
Day 50 MA	$41.17
Day 200 MA	$35.40

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date